HIV Point of Care (POC) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
HIV Point of Care (POC) Pipeline Market Report Overview
HIV Point of care (POC) Tests are rapid tests that are carried out outside of the laboratory setting and are used as a presumptive diagnosis prior to confirmatory laboratory testing. The HIV Point of care (POC) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The United States
· Europe · Japan · India · The United Kingdom |
| Key Regulatory Paths | · 510(k)
· CE-IVD · NMPA · CE · HSA |
| Leading Companies | · Abbott Diagnostics
· Aldatu Biosciences Inc · Altratech Ltd · Atomo Diagnostics Ltd · Baebies Inc |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
HIV Point of Care Tests Pipeline Market Segmentation by Territories
A few of the key territories associated with the HIV POC Tests pipeline market are Europe, the United States, India, Japan, and the United Kingdom among others. As of September 2024, the US had the highest number of HIV POC test pipeline products.
HIV POC Tests Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the HIV POC Tests Pipeline Market
HIV Point of Care Tests Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the HIV POC Tests pipeline products market are 510(k), CE-IVD, NMPA, CE, and HSA. As of September 2024, CE-IVD was the most followed pathway for pipeline products in the HIV POC Tests market.
HIV POC Tests Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the HIV POC Tests Pipeline Market
HIV Point of Care Tests Pipeline Market – Competitive Landscape
A few of the key companies associated with the HIV POC Tests pipeline market are Abbott Diagnostics, Aldatu Biosciences Inc, Altratech Ltd, Atomo Diagnostics Ltd, and Baebies Inc among others.
Abbott Diagnostics (Abbott): Abbott Diagnostics (Abbott) a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers various core laboratory products, molecular point-of-care products, transfusion medicine, professional services, and diagnostics. Abbott’s product portfolio includes laboratory systems for automation molecular diagnostic systems and point-of-care systems for blood analysis. The company products find application in therapeutic drug monitoring, measurement of antibodies and antigens, and screening and diagnosis of cancer.
Altratech Ltd (Altratech): Altratech Ltd (Altratech) is a biotechnology company that is engaged in developing nanotechnology-based products for monitoring viral contagious diseases. The company is headquartered in Ireland.
HIV POC Tests Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the HIV POC Tests Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
HIV Point of Care (POC) Tests Pipeline Market Territories Outlook (2024)
- Europe
- The United States
- India
- Japan
- The UK
HIV Point of Care (POC) Tests Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- CE-IVD
- NMPA
- CE
- HSA
Scope
- The report provides extensive coverage of the HIV Point of care (POC) Tests under development.
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
- The report reviews the major players involved in the development of HIV Point of care (POC) Tests and lists all their pipeline projects.
- The report covers the pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage.
- The report provides key clinical trial data of ongoing trials specific to pipeline products.
- The report entails recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of HIV Point of care (POC) Tests under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Aldatu Biosciences Inc
Altratech Ltd
Atomo Diagnostics Ltd
Baebies Inc
BBB Technologies Inc
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Binx Health Inc
Bio-AMD Inc
Biocartis Group NV
BioHelix Corp
Bluejay Diagnostics Inc
Calypte Biomedical Corporation
Centre International de Reference Chantal Biya
Cepheid Inc
ChipCare Corp
CrossLife Technologies Inc
Cue Inc
Daktari Diagnostics, Inc.
Diagnostics For All Inc
Diagnostics for the Real World (Europe) Ltd
Endeavor Sciences Inc
Epinex Diagnostics Inc
ERBA Molecular Ltd
Fluid Discovery Inc
Fluxergy LLC
GAIA Medical Institute LLC
genedrive plc
Group K Diagnostics
Guangzhou Wondfo Biotech Co Ltd
HA TECH Pty Ltd
HeatFlow Technologies Inc
Identifysensors LLC
Imperial College London
Integrated Diagnostics Inc (Inactive)
Intuitive Biosciences Inc
Jan Biotech Inc
Jinvator Bio Med GmbH
Johns Hopkins University
Lynntech Inc
Maxim Biomedical Inc
MedMira Inc
Micronics Inc
Nanobiosym Inc
Newmark Diagnostics LLC
Northwestern University
Open Bioeconomy Lab
Osel Inc
Philmedi Co Ltd
Prenetics Ltd
QuantuMDx Group Ltd
Quidel Corp
Radisens Diagnostics Ltd
Rheonix Inc
Roche Diagnostics International Ltd
SD Biosensor Inc
Sedia Biosciences Corp
Sensible Diagnostics Inc
Senzo Inc
TheoremDx Inc
TNF Pharmaceuticals Inc
Trinity Biotech Plc
University of Connecticut
University of Minnesota
University of the Western Cape
UrSure Inc
Ustar Biotechnologies (Hangzhou) Ltd
Virax Biolabs Group Ltd
Wave 80 Biosciences Inc
Yaathum Biotech Pvt Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the HIV POC Tests pipeline market as of September 2024?
As of September 2024, the US had the highest number of HIV POC test pipeline products.
-
Which was the most followed regulatory pathway in the HIV POC Tests pipeline market as of September 2024?
As of September 2024, CE-IVD was the most followed pathway for pipeline products in the HIV POC Tests market.
-
Which are the major companies operating in the HIV POC Tests pipeline market?
A few of the key companies associated with the HIV POC Tests pipeline market are Abbott Diagnostics, Aldatu Biosciences Inc, Altratech Ltd, Atomo Diagnostics Ltd, and Baebies Inc among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
HIV Point of Care (POC) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more HIV Point of care (POC) Tests reports
